Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee weighs no-cost PrEP/PEP coverage, 340B protections; decision held for more information
Summary
Legislative counsel presented amendments to require insurer coverage of HIV prevention drugs without cost-sharing and to prohibit 340B suppliers from conditioning access on claims data. Medicaid cautioned about rebate and management impacts; the committee agreed to hold the measure until Tuesday and requested information by Monday 2:00 p.m.
Legislative counsel told the Health & Welfare Committee on April 23 that draft amendments would require health insurance plans to cover HIV prevention drugs — including PrEP and PEP in oral and long-acting injectable forms approved by the FDA — with no deductible, coinsurance, copayment, prior authorization or step therapy.
Counsel said the package also adds a provision to protect 340B-covered entities: it would bar a prescription drug manufacturer or its agent from requiring a 340B covered entity or contract…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
